Related Experiment Video
Updated: May 10, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Lycopene modulates growth and survival associated genes in prostate cancer
Mohamed M Rafi1, Saravanan Kanakasabai, Marynell D Reyes
1Department of Food Science, School of Environmental and Biological Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ08901, USA.
Abstract:
Lycopene is a fat soluble red-orange carotenoid pigment present in tomato that reduces the risk for prostate cancer, a common malignancy among men. However, the mechanism by which lycopene attenuates prostate cancer is not fully defined. In this study we examined the effect of lycopene on proliferation, survival, and biomarker gene expression in prostate cancer (PC-3) cells in culture. WST-1 assay showed that lycopene induces a biphasic effect on PC-3 cells with a modest increase in proliferation at 1-5 μM, no change at 10-25 μM and a decrease at 50-100 μM doses in culture. Interestingly, combination treatment with lycopene induced anti-proliferative effect of Temozolomide on PC-3 cells. Lycopene also augmented the anti-proliferative effect of peroxisome proliferator-activated receptor gamma (PPARγ) agonists, but not Doxorubicin or Taxol, in prostate cancer. Flow cytometry analyses showed that lycopene, in combination with chemotherapeutic agents and PPARγ agonists, induced modest cell cycle arrest with significant increase in cell death by apoptosis and necrosis on prostate cancer. Gene array and quantitative reverse transcription polymerase chain reaction analyses showed that lycopene alters the expression of growth and apoptosis associated biomarkers in PC-3 cells. These findings highlight that lycopene attenuates prostate cancer by modulating the expression of growth and survival associated genes.
Insights
Lycopene, a tomato pigment, shows potential in fighting prostate cancer by affecting cell growth and survival. It modulates gene expression and enhances the effects of certain cancer therapies.
Area of Science:
- Nutritional biochemistry
- Cancer biology
- Molecular oncology
Background:
- Lycopene, a carotenoid from tomatoes, is linked to reduced prostate cancer risk.
- The precise mechanisms of lycopene's anti-cancer effects remain unclear.
- Prostate cancer remains a significant health concern for men worldwide.
Purpose of the Study:
- To investigate lycopene's impact on prostate cancer cell proliferation, survival, and gene expression.
- To explore lycopene's synergistic effects with chemotherapeutic agents and PPARγ agonists.
- To elucidate the molecular pathways through which lycopene influences prostate cancer cells.
Main Methods:
- Utilized WST-1 assay for proliferation studies on PC-3 prostate cancer cells.
- Employed flow cytometry to analyze cell cycle arrest, apoptosis, and necrosis.
- Conducted gene array and quantitative reverse transcription polymerase chain reaction (RT-qPCR) for biomarker analysis.
Main Results:
- Lycopene exhibited a biphasic effect on PC-3 cell proliferation: increasing at low doses (1-5 μM) and decreasing at higher doses (50-100 μM).
- Lycopene enhanced the anti-proliferative effects of Temozolomide and PPARγ agonists, but not Doxorubicin or Taxol.
- Lycopene induced cell cycle arrest and increased apoptosis/necrosis, particularly when combined with other agents.
- Gene expression analysis revealed lycopene's modulation of growth and apoptosis-associated biomarkers.
Conclusions:
- Lycopene demonstrates dose-dependent effects on prostate cancer cell proliferation.
- Lycopene potentiates the anti-cancer activity of specific chemotherapeutic agents and PPARγ agonists.
- Lycopene attenuates prostate cancer progression by altering the expression of critical growth and survival genes.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...